查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600753

药物释放型球市场：按类型、涂层技术和最终用户划分 - 2025-2030 年全球预测

Drug Eluting Balloon Market by Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon), Coating Technology (EnduraCoat, FreePac, Paccocath), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药物释放型球囊市值为9,6584万美元，预计2024年将达到109831万美元，复合年增长率为15.51%，预计2030年将达到265047万美元。

药物释放型球囊（DEB）是主要用于介入心臟病学领域的医疗设备。 DEB 将传统血管成形术用气球的机械特性与药物释放型的製药优势相结合，描述了一种治疗血管疾病的创新解决方案。 DEB 市场受到心血管疾病盛行率上升、微创手术意识不断增强以及医疗设备技术进步的推动。在冠状动脉疾病和周边动脉疾病的治疗中，透过直接向受影响区域施用抗增殖药物来解决再血管再阻塞。最终用途包括医院、门诊手术中心和专科诊所，这大大推动了 DEB 的需求。

主要市场统计
基准年[2023] 9.6584亿美元
预测年份 [2024] 1,098,310,000 美元
预测年份 [2030] 26.5047亿美元
复合年增长率（%） 15.51%

由于世界老化和慢性病的增加，该市场显示出广泛的成长潜力。专注于改进药物配方和易于使用的输送机制的创新产品设计可以帮助您利用潜在的商机。透过进入医疗基础设施逐渐改善的新兴市场，可以进一步扩大市场。然而，严格的监管条件以及高昂的程序和产品开发成本是主要限制因素。成长也受到球囊滑移和药物输送不一致等技术挑战的阻碍。

创新应致力于提高药物释放的有效性并扩大可透过 DEB 输送的药物范围。开发解决方案来克服技术障碍并提高製造成本效益是一个及时的研究领域。设备製造商和製药公司之间的合作可以加速新产品的开发。市场仍然充满活力，强大的竞争环境推动着持续的成长和适应。透过有针对性的研究和策略联盟来应对这些挑战，相关人员可以显着影响 DEB 市场的发展轨迹。

市场动态：揭示快速发展的药物释放型球囊市场的关键市场洞察

供需的动态交互作用正在改变药物释放型球囊市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 老年人增加导致心血管疾病
    • 周边动脉疾病和冠状动脉疾病的盛行率上升
    • 有利的核准支持 DEB 的发展
  • 市场限制因素
    • 药物释放型球囊召回问题
  • 市场机会
    • 药物涂层球囊导管临床应用新进展
    • 药物涂层球囊的进展、创新与研究
  • 市场问题
    • 缺乏熟练的专业人员

波特五力：驾驭药物释放型球囊市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物释放型球市场的外部影响

外部宏观环境因素在塑造药物释放型球市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解药物释放型球囊市场的竞争格局

药物释放型球市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：药物释放型球囊市场供应商的绩效评估

FPNV定位矩阵是评估药物释放型球囊市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键焦点细分市场的全面市场分析。

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老年人口数量增加导致心血管疾病
      • 周边动脉疾病和冠状动脉疾病的盛行率增加
      • 良好的核准支持 DEB 的发展
    • 抑制因素
      • 与药物释放型球囊产品召回相关的问题
    • 机会
      • 药物涂层球囊导管临床应用新进展
      • 药物涂层球囊的进展、创新与研究
    • 任务
      • 缺乏熟练且训练有素的专业人员
  • 市场区隔分析
    • 类型：冠状动脉 DEB 在改善递送和药物迁移的重要性
    • 包衣技术：enduraCoat 因其卓越的局部药物释放特性而越来越受欢迎
    • 最终用户：易用性和程序速度提高了导管实验室 DEB 的采用率
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境
  • 客户客製化

第六章药物释放型球市场：依类型

  • 介绍
  • 冠状动脉涂药气球
  • 周边设备药物释放型球囊

第七章药物释放型球市场：涂层技术

  • 介绍
  • EnduraCoat
  • FreePac
  • 帕科卡斯
  • 跨太平洋运输公司

第八章药物释放型球囊市场：依最终用户分类

  • 介绍
  • 门诊手术中心
  • 导管实验室
  • 医院

第九章美洲药物释放型球市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太药物释放型球囊市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲药物释放型气球市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Advanced NanoTherapies (ANT) 获得 400 万美元战略投资，加速 SirPlux Duo 药物涂层球囊 (DCB) 的临床开发，用于治疗新型冠状动脉疾病 (CAD)
    • Translumina 收购 Blue Medical Devices 进一步强化技术组合
    • Surmodics 的 SurVeil 药物涂层球囊获得 FDA核准

公司名单

  • Medtronic PLC
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • MA Med Alliance SA by Cordis Corporation
  • Eurocor Tech GmbH
  • Lepu Medical Technology
  • Invamed
  • BIoTronik SE & Co. KG
  • Cook Medical, Inc.
  • Terumo Corporation
  • Cardionovum GmbH
  • SurModics, Inc.
  • Johnson & Johnson Services, Inc.
  • Balton Sp. z oo
  • B. Braun Melsungen AG
  • Bayer AG
  • Abbott Laboratories
  • Wellinq
  • Laborie Medical Technologies, Inc.
  • Concept Medical
  • Zylox-Tonbridge Medical Technology Co., Ltd.
  • Biosensors International Group, Ltd.
  • Koninklijke Philips NV
  • iVascular SLU
Product Code: MRR-4348D129FA8E

The Drug Eluting Balloon Market was valued at USD 965.84 million in 2023, expected to reach USD 1,098.31 million in 2024, and is projected to grow at a CAGR of 15.51%, to USD 2,650.47 million by 2030.

A Drug Eluting Balloon (DEB) is a medical device used primarily in the field of interventional cardiology. It combines the mechanical feature of a traditional angioplasty balloon with the pharmaceutical benefits of drug elution, providing an innovative solution for treating vascular diseases. The DEB market is driven by the rising prevalence of cardiovascular diseases, increasing awareness regarding minimally invasive procedures, and technological advancements in healthcare devices. Crucial to its application are the treatments for coronary artery disease and peripheral artery disease, addressing restenosis by delivering anti-proliferative drugs directly to the affected site. End-use scope includes hospitals, ambulatory surgical centers, and specialized clinics, significantly driving the demand for DEBs.

KEY MARKET STATISTICS
Base Year [2023] USD 965.84 million
Estimated Year [2024] USD 1,098.31 million
Forecast Year [2030] USD 2,650.47 million
CAGR (%) 15.51%

The market shows promising growth potential, fueled by the increasing global aging population and subsequent rise in chronic disease occurrences. Potential opportunities can be harnessed through innovative product designs focusing on improved drug formulations and user-friendly delivery mechanisms. Further market expansion can be achieved by entering emerging markets where healthcare infrastructure is progressively improving. However, stringent regulatory landscapes and high costs of procedure and product development are key limitations. Technical challenges such as balloon slippage and inconsistent drug delivery also hinder growth.

Innovation should be directed towards enhancing the efficacy of drug release and expanding the range of drugs that can be delivered via DEBs. Developing solutions to overcome technical barriers and improving the cost-effectiveness of production are areas ripe for research. Collaborations between device manufacturers and pharmaceutical companies could foster new product developments. The market remains dynamic, with a strong competitive environment encouraging continuous growth and adaptation. By addressing these challenges through targeted research and strategic collaborations, stakeholders can significantly influence the trajectory of the DEB market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Eluting Balloon Market

The Drug Eluting Balloon Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Geriatric Population Leading to Cardiovascular Diseases
    • Rising Prevalence of Peripheral and Coronary Artery Diseases
    • Favorable Approvals to Support the Growth of DEBs
  • Market Restraints
    • Issues Associated to Product Recalls of Drug-Eluting Balloons
  • Market Opportunities
    • New Developments in the Clinical Use of Drug-Coated Balloon Catheters
    • Advancement, Innovation, and Research in Drug-Coated Balloons
  • Market Challenges
    • Lack of Availability for Skilled and Trained Professionals

Porter's Five Forces: A Strategic Tool for Navigating the Drug Eluting Balloon Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Eluting Balloon Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Eluting Balloon Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Eluting Balloon Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Eluting Balloon Market

A detailed market share analysis in the Drug Eluting Balloon Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Eluting Balloon Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Eluting Balloon Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Drug Eluting Balloon Market, highlighting leading vendors and their innovative profiles. These include Medtronic PLC, Becton, Dickinson and Company, Boston Scientific Corporation, M.A. Med Alliance SA by Cordis Corporation, Eurocor Tech GmbH, Lepu Medical Technology, Invamed, Biotronik SE & Co. KG, Cook Medical, Inc., Terumo Corporation, Cardionovum GmbH, SurModics, Inc., Johnson & Johnson Services, Inc., Balton Sp. z o. o., B. Braun Melsungen AG, Bayer AG, Abbott Laboratories, Wellinq, Laborie Medical Technologies, Inc., Concept Medical, Zylox-Tonbridge Medical Technology Co., Ltd., Biosensors International Group, Ltd., Koninklijke Philips N.V., and iVascular S.L.U..

Market Segmentation & Coverage

This research report categorizes the Drug Eluting Balloon Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Coronary Drug Eluting Balloon and Peripheral Drug Eluting Balloon.
  • Based on Coating Technology, market is studied across EnduraCoat, FreePac, Paccocath, and TransPax.
  • Based on End User, market is studied across Ambulatory Surgery Centers, Cath Labs, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Geriatric Population Leading to Cardiovascular Diseases
      • 5.1.1.2. Rising Prevalence of Peripheral and Coronary Artery Diseases
      • 5.1.1.3. Favorable Approvals to Support the Growth of DEBs
    • 5.1.2. Restraints
      • 5.1.2.1. Issues Associated to Product Recalls of Drug-Eluting Balloons
    • 5.1.3. Opportunities
      • 5.1.3.1. New Developments in the Clinical Use of Drug-Coated Balloon Catheters
      • 5.1.3.2. Advancement, Innovation, and Research in Drug-Coated Balloons
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Availability for Skilled and Trained Professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Significance of coronary DEBs in enhancing deliverability and drug transfer
    • 5.2.2. Coating Technology: Growing preferences for enduraCoat with better local drug release profile
    • 5.2.3. End User: Higher adoption of DEBs in Cath Labs owing to ease of use and speed of the procedure
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Drug Eluting Balloon Market, by Type

  • 6.1. Introduction
  • 6.2. Coronary Drug Eluting Balloon
  • 6.3. Peripheral Drug Eluting Balloon

7. Drug Eluting Balloon Market, by Coating Technology

  • 7.1. Introduction
  • 7.2. EnduraCoat
  • 7.3. FreePac
  • 7.4. Paccocath
  • 7.5. TransPax

8. Drug Eluting Balloon Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Cath Labs
  • 8.4. Hospitals

9. Americas Drug Eluting Balloon Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Eluting Balloon Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Eluting Balloon Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Advanced NanoTherapies (ANT) Secures USD 4 Million Strategic Investment to Accelerate Clinical Development of SirPlux Duo Drug-Coated Balloon (DCB) for Treating de novo Coronary Artery Disease (CAD)
    • 12.3.2. Translumina further Strengthens Its Technology Portfolio with Acquisition of Blue Medical Devices, Netherlands
    • 12.3.3. Surmodics Receives FDA Approval for the SurVeil Drug-Coated Balloon

Companies Mentioned

  • 1. Medtronic PLC
  • 2. Becton, Dickinson and Company
  • 3. Boston Scientific Corporation
  • 4. M.A. Med Alliance SA by Cordis Corporation
  • 5. Eurocor Tech GmbH
  • 6. Lepu Medical Technology
  • 7. Invamed
  • 8. Biotronik SE & Co. KG
  • 9. Cook Medical, Inc.
  • 10. Terumo Corporation
  • 11. Cardionovum GmbH
  • 12. SurModics, Inc.
  • 13. Johnson & Johnson Services, Inc.
  • 14. Balton Sp. z o. o.
  • 15. B. Braun Melsungen AG
  • 16. Bayer AG
  • 17. Abbott Laboratories
  • 18. Wellinq
  • 19. Laborie Medical Technologies, Inc.
  • 20. Concept Medical
  • 21. Zylox-Tonbridge Medical Technology Co., Ltd.
  • 22. Biosensors International Group, Ltd.
  • 23. Koninklijke Philips N.V.
  • 24. iVascular S.L.U.

LIST OF FIGURES

  • FIGURE 1. DRUG ELUTING BALLOON MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG ELUTING BALLOON MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DRUG ELUTING BALLOON MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DRUG ELUTING BALLOON MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG ELUTING BALLOON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG ELUTING BALLOON MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CORONARY DRUG ELUTING BALLOON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PERIPHERAL DRUG ELUTING BALLOON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY ENDURACOAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY FREEPAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PACCOCATH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TRANSPAX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CATH LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. DRUG ELUTING BALLOON MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. DRUG ELUTING BALLOON MARKET, FPNV POSITIONING MATRIX, 2023